AB177. Does efficacy of premature ejaculation therapy depend on duration of the disease?

Transl Androl Urol, Vol 3, Suppl 1 September 2014 www.amepc.org/tau © Translational Andrology and Urology. All rights reserved. the CIPE-5 increased, reaching an average of 19.86±0.24 (P<0.001), but scores on the IIEF-5 decreased reaching an average of 19.86±0.16 (P>0.05). The second group had the following results: IELT increased, reaching an average, 7.61±0.32 (P<0.001). Summary on the same score in the CIPE-5 increased, on average 22.70±0.37 (P<0.001), and scores on the IIEF-5 increased reaching an average of 23.28±0.10 (P>0.05). In the third group IELT was on average, 2.94±0.33 min (P<0.05). Summary on the same score in the CIPE-5 was on average 12.15±0.67 (P<0.05), but scores on the IIEF-5 increased reaching an average of 23.67±0.14 (P>0.05). Conclusions: Therapy of patients who is suffering from premature ejaculation by applying serotonin reuptake inhibitors in combination with inhibitors of phosphodiesterase type-5 is safe and more effective against other groups.